Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/126504
Full metadata record
DC FieldValueLanguage
dc.creatorFerreira, JR-
dc.creatorTeixeira, GQ-
dc.creatorSantos, SG-
dc.creatorBarbosa, MA-
dc.creatorAlmeida-Porada, G-
dc.creatorGonçalves, RM-
dc.date.accessioned2020-03-02T10:34:14Z-
dc.date.available2020-03-02T10:34:14Z-
dc.date.issued2018-
dc.identifier.issn1664-3224-
dc.identifier.urihttps://hdl.handle.net/10216/126504-
dc.description.abstractMesenchymal stromal cells (MSCs) are self-renewing, culture-expandable adult stem cells that have been isolated from a variety of tissues, and possess multipotent differentiation capacity, immunomodulatory properties, and are relatively non-immunogenic. Due to this unique set of characteristics, these cells have attracted great interest in the field of regenerative medicine and have been shown to possess pronounced therapeutic potential in many different pathologies. MSCs' mode of action involves a strong paracrine component resulting from the high levels of bioactive molecules they secrete in response to the local microenvironment. For this reason, MSCs' secretome is currently being explored in several clinical contexts, either using MSC-conditioned media (CM) or purified MSC-derived extracellular vesicles (EVs) to modulate tissue response to a wide array of injuries. Rather than being a constant mixture of molecular factors, MSCs' secretome is known to be dependent on the diverse stimuli present in the microenvironment that MSCs encounter. As such, the composition of the MSCs' secretome can be modulated by preconditioning the MSCs during in vitro culture. This manuscript reviews the existent literature on how preconditioning of MSCs affects the therapeutic potential of their secretome, focusing on MSCs' immunomodulatory and regenerative features, thereby providing new insights for the therapeutic use of MSCs' secretome.-
dc.description.sponsorshipWe would like to acknowledge Norte Portugal Regional Operational Programme (NORTE 2020) in the framework of the project “Bioengineered Therapies for Infectious Diseases and Tissue Regeneration” (NORTE-01-0145-FEDER-000012). We also acknowledge Fundação para a Ciência e a Tecnologia (FCT) and Fundo Europeu de Desenvolvimento Regional (FEDER) funds through the COMPETE 2020-Operacional Programme for Competitiveness and Internationalization (POCI), Portugal 2020-in the framework of the project “Institute for Research and Innovation in Health Sciences” (POCI-01-0145-FEDER-007274). We also acknowledge EUROSPINE TRF for the funded project “Disc Regeneration, Immuno, and Neuro Modulation” , ref. 2017_05 . In addition, JF and RG also acknowledge FCT for funding the BiotechHealth Ph.D. fellowship (PD/BD/135486/2018) and the FCT Investigator Grant (IF/00638/2014), respectively.-
dc.language.isoeng-
dc.publisherFrontiers Media-
dc.relation.ispartofFrontiers in Immunology, vol.9:2837-
dc.rightsopenAccess-
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.subjectimmunomodulation-
dc.subjectMSCs (Mesenchymal Stromal Cells)-
dc.subjectpre-conditioning-
dc.subjectregeneration-
dc.subjectsecretome-
dc.subjecttherapeutic potential-
dc.titleMesenchymal Stromal Cell Secretome: Influencing Therapeutic Potential by Cellular Pre-conditioning-
dc.typeArtigo em Revista Científica Internacional-
dc.contributor.uportoInstituto de Investigação e Inovação em Saúde-
dc.identifier.doi10.3389/fimmu.2018.02837-
dc.relation.publisherversionhttps://www.frontiersin.org/articles/10.3389/fimmu.2018.02837/full-
Appears in Collections:I3S - Artigo em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
10.3389-fimmu.2018.02837.pdf1.01 MBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons